Physician profile
Hose Kim
NPI 1710107842
$543.53
in general payments reported to CMS, 2019-2025
8 companies · $47.33 in 2025
The $47.33 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $32.80 · 2021: $63.09 · 2022: $87.08 · 2023: $71.42 · 2024: $86.18 · 2025: $47.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $341.20 | 2019-2025 | Supartz Fx Sodium Hyaluronate, Supartz Fx Sodium Hyaluronate, Durolane |
| Anika Therapeutics, INC. | $63.09 | 2021 | |
| Depuy Synthes Sales INC. | $32.05 | 2020-2024 | Monovisc |
| Stryker Corporation | $27.13 | 2023 | Augment Injectable |
| Convatec INC. | $23.79 | 2024 | |
| Vision Quest Industries INC. | $22.75 | 2024 | Trulign Oa Kbr M/L Rgt |
| Team_makena_llc | $16.97 | 2020 | |
| Pacira Therapeutics, INC. | $16.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hose Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.